Transplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients
Sponsor: CHU de Quebec-Universite Laval
Listed as NCT02196467, this PHASE1/PHASE2 trial focuses on Duchenne Muscular Dystrophy and remains ongoing. Sponsored by CHU de Quebec-Universite Laval, it has been updated 11 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE1/PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE1/PHASE2
Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Feb 2024 — Jul 2024 [monthly]
Unknown Status PHASE1_PHASE2
Status: Recruiting → Unknown Status
-
Feb 2021 — Feb 2024 [monthly]
Recruiting PHASE1_PHASE2
▶ Show 6 earlier versions
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE1_PHASE2
-
Aug 2019 — Jan 2021 [monthly]
Recruiting PHASE1_PHASE2
-
Aug 2018 — Aug 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Jul 2017 — Jun 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2017 — Jul 2017 [monthly]
Recruiting PHASE1_PHASE2
First recorded
May 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CHU de Quebec-Universite Laval
For direct contact, visit the study record on ClinicalTrials.gov .